Clinical Trials

Clinical Trials at Attune Health

Our physicians serve as the Principal Investigators for our state-of-the-art clinical trial center where we are currently participating in tests for new and FDA-approved medications for various rheumatic disease conditions. Clinical trials are a way for patients who are not responding to traditional therapies to try new medications before they are commercially available and, in some cases, a way for patients who are uninsured or underinsured to receive expert medical care from our practice. Attune Health believes in the ethical conduct of medical research and offers our patients all possible alternatives in their care.


Attune Health is now involved in several trials for Rheumatoid Arthritis, Systemic Lupus Erythematosus, Myositis, Sjogren’s syndrome and vasculitis. Please contact our office if you’re interested in learning more about our clinical trial program.

  • Attune Health providers Dr. Venturupalli and Bryant Uy walking down hallway

    Slide title

    Write your caption here
    Button
Contact our Research Team

Now Enrolling for the following Clinical Trials:

  • Rheumatoid Arthritis

    Rheumatoid Arthritis


    Now Enrolling!


    Attune Health Research is enrolling for a clinical trial for subjects who have Rheumatoid Arthritis.


    What is it?

    Researchers are evaluating an investigational drug’s ability to find inflammatory cells in joints with rheumatoid arthritis and to determine the relationship with the different types of cells present in joints affected RA.


    Who May Qualify?

    • Are at least 18 years of age.
    • Diagnosed by a physician with Rheumatoid Arthritis.

    What will you receive?

    • Study assessments and procedures at no cost.
    • Stipend for each completed study visit.
    • Contributing to the possible benefit of future patients with Rheumatoid Arthritis.

    Want more info?

    Contact our research department at [email protected]

  • Myositis

    Myositis


    Now Enrolling!


    Attune Health Research is enrolling for a clinical trial in Active Idiopathic Inflammatory Myopathies, which includes:

    • Dermatomyositis
    • Immune Mediated Necrotizing Myopathy
    • Anti-Synthetase Syndrome

    What is it?

     Researchers are evaluating an investigational drug to see if it can be used to treat participants with an Active Idiopathic Inflammatory Myopathy Diagnosis.


    Who May Qualify?

    • Are at least 18 years of age.
    • Diagnosed by a physician with an Active Idiopathic Inflammatory Myopathy and currently have active disease.
    • Must be on a standard treatment for Idiopathic Inflammatory Myopathies, such as an Immunosuppressant or Glucocorticoid.

    What will you receive?

    • All participants will receive study intervention, with an opportunity to have access to the study drug for 1-year after completing the main study
    • Study assessments and procedures at no cost (including standard of care procedures and assessments)
    • Stipend for each completed study visit.

    Want more info?

    Contact our research department at [email protected]